Skip to main content


You are viewing the new article page. Let us know what you think. Return to old version

Research news | Open | Published:

Sir inhibitor

Sir2p is an NAD-dependent histone deacetylase that is involved in chromatin silencing. In the December 18 Proceedings of the National Academy of Sciences, Antonio Bedalov and colleagues at the Fred Hutchinson Cancer Research Center describe the isolation of splitomicin, an inhibitor of Sir2p activity (Proc Natl Acad Sci USA 2001, 98:15113-15118). They performed a genetic screen for compounds that inhibit silencing of telomeric or mating-type loci in yeast. This led them to a compound, 1,2-dihydro-3H-naptho[2,1b]pyran-3-one, which they named splitomicin; it phenocopies sir2 mutation by inhibiting histone deacetylase activity. Whole-genome microarray analysis confirmed that splitomicin affects genes silenced by Sir2p. Bedalov et al.used splitomicin to demonstrate that Sir2p histone deacetylase activity is required to maintain the silenced state in non-dividing cells.


  1. 1.

    The Sir proteins of Saccharomyces cerevisiae: mediators of transcriptional silencing and much more.

  2. 2.

    Proceedings of the National Academy of Sciences , []

  3. 3.

    Fred Hutchinson Cancer Research Center, []

Download references

Rights and permissions

Reprints and Permissions

About this article


  • Cancer Research
  • Microarray Analysis
  • Histone Deacetylase
  • Inhibit Histone Deacetylase
  • Genetic Screen